Impact of timing following acute myocardial infarction on efficacy and safety of bone marrow stem cells therapy: A network meta-analysis

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Liu, Bei ^a   Duan, Chong Yang ^a   Luo, Cheng Feng ^b   Ou, Cai Wen ^a   Wu, Zhi Ye ^a   Zhang, Jian Wu ^a   Ni, Xiao Bin ^a   Chen, Ping Yan ^a   Chen, Min Sheng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; BONE MARROW STEM CELL THERAPY; CLINICAL EFFECTIVENESS; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL; THERAPY EFFECT; TIME TO TREATMENT; TREND STUDY;

EID: 84953897688     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/1031794     Document Type: Review

References (55)

1. V. Jeevanantham, M. Butler, A. Saad, A. Abdel-Latif, E. K. Zuba-Surma, and B. Dawn, "Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis, " Circulation, vol. 126, no. 5, pp. 551-568, 2012.
2. R. Delewi, A. Hirsch, J. G. Tijssen et al. , "Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis, " European Heart Journal, vol. 35, no. 15, pp. 989-998, 2014.
3. E. Martin-Rendon, S. J. Brunskill, C. J. Hyde, S. J. Stanworth, A. Mathur, and S. M. Watt, "Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review, " European Heart Journal, vol. 29, no. 15, pp. 1807-1818, 2008.
4. J. Bartunek, W. Wijns, G. R. Heyndrickx, and M. Vanderheyden, "Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction, " Nature Clinical Practice CardiovascularMedicine, vol. 3, supplement 1, pp. S52-S56, 2006.
5. B.-E. Strauer and G. Steinhoff, "10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice, " Journal of the American College of Cardiology, vol. 58, no. 11, pp. 1095-1104, 2011.
6. D. Surder, J. Schwitter, T. Moccetti et al. , "Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISSAMI), " American Heart Journal, vol. 160, no. 1, pp. 58-64, 2010.
7. B. Assmus, D. M. Leistner, V. Schachinger et al. , "Longterm clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acutemyocardial infarction: migratory capacity of administered cells determines eventfree survival, " European Heart Journal, vol. 35, no. 19, pp. 1275-1283, 2014.
8. J. H. Traverse, T. D. Henry, C. J. Pepine et al. , "Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial, " Journal of the American Medical Association, vol. 308, pp. 2380-2389, 2012.
9. J. H. Traverse, T. D. Henry, S. G. Ellis et al. , "Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial, " The Journal of the AmericanMedical Association, vol. 306, no. 19, pp. 2110-2119, 2011.
10. S. Leucht, A. Cipriani, L. Spineli et al. , "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, " The Lancet, vol. 382, no. 9896, pp. 951-962, 2013.
11. P. Juni, D. G. Altman, and M. Egger, "Systematic reviews in health care: assessing the quality of controlled clinical trials, " British Medical Journal, vol. 323, no. 7303, pp. 42-46, 2001.
12. M. F. Piepoli, D. Vallisa, M. Arbasi et al. , "Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study), " European Journal of Heart Failure, vol. 12, no. 2, pp. 172-180, 2010.
13. R. G. Turan, T. I. Bozdag, C. H. Turan et al. , "Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction, " Journal of Cellular and Molecular Medicine, vol. 16, no. 4, pp. 852-864, 2012.
14. J. Meluzin, S. Janousek, J. Mayer et al. , "Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrowcells in patientswith acutemyocardial infarction, " International Journal of Cardiology, vol. 128, no. 2, pp. 185-192, 2008.
15. J. Wohrle, F. von Scheidt, P. Schauwecker et al. , "Impact of cell number and microvascular obstruction in patients with bonemarrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial, " Clinical Research in Cardiology, vol. 102, no. 10, pp. 765-770, 2013.
16. B. Assmus, A. Rolf, S. Erbs et al. , "Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction, " Circulation: Heart Failure, vol. 3, no. 1, pp. 89-96, 2010.
17. T. Dill, V. Schachinger, A. Rolf et al. , "Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction study (REPAIRAMI) cardiacmagnetic resonance imaging substudy, " American Heart Journal, vol. 157, no. 3, pp. 541-547, 2009.
18. V. Schachinger, S. Erbs, A. Elsasser et al. , "Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction, " The New England Journal of Medicine, vol. 355, no. 12, pp. 1210-1221, 2006.
19. F. Cao, D. Sun, C. Li et al. , "Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up, " European Heart Journal, vol. 30, no. 16, pp. 1986-1994, 2009.
20. M. Plewka, M. Krzeminska-Pakula, P. Lipiec et al. , "Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction, " American Journal of Cardiology, vol. 104, no. 10, pp. 1336-1342, 2009.
21. M. Plewka, M. Krzeminska-Pakula, J. Z. Peruga et al. , "The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results, " Kardiologia Polska, vol. 69, no. 12, pp. 1234-1240, 2011.
22. K. Yao, R. Huang, A. Sun et al. , "Repeated autologous bonemarrowmononuclear cell therapy in patients with largemyocardial infarction, " European Journal of Heart Failure, vol. 11, no. 7, pp. 691-698, 2009.
23. S. Grajek, M. Popiel, L. Gil et al. , "Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial, " European Heart Journal, vol. 31, no. 6, pp. 691-702, 2010.
24. G. P. Meyer, K. C. Wollert, J. Lotz et al. , "Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial, " Circulation, vol. 113, no. 10, pp. 1287-1294, 2006.
25. K. C. Wollert, G. P. Meyer, J. Lotz et al. , "Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial, " The Lancet, vol. 364, no. 9429, pp. 141-148, 2004.
26. M. Castellani, A. Colombo, R. Giordano et al. , "The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection, " Journal of Nuclear Medicine, vol. 51, no. 12, pp. 1908-1916, 2010.
27. L. R. Gao, X. T. Pei, Q. A. Ding et al. , "A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction, " International Journal of Cardiology, vol. 168, no. 4, pp. 3191-3199, 2013.
28. A. Colombo, M. Castellani, E. Piccaluga et al. , "Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial, " Journal of Cardiovascular Medicine, vol. 12, no. 4, pp. 239-248, 2011.
29. M. Penicka, J. Horak, P. Kobylka et al. , "Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study, " Journal of the American College of Cardiology, vol. 49, no. 24, pp. 2373-2374, 2007.
30. F. B. D. S. Nogueira, S. A. Silva, A. F. Haddad et al. , "Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation, " Arquivos Brasileiros de Cardiologia, vol. 93, no. 4, pp. 372-374, 2009.
31. D. Surder, R. Manka, V. Lo Cicero et al. , "Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function, " Circulation, vol. 127, no. 19, pp. 1968-1979, 2013.
32. J. H. Traverse, D. H. McKenna, K. Harvey et al. , "Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stemcell administration in patients following ST-elevation myocardial infarction, " American Heart Journal, vol. 160, no. 3, pp. 428-434, 2010.
33. S.-L. Chen, W.-W. Fang, F. Ye et al. , "Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction, " American Journal of Cardiology, vol. 94, no. 1, pp. 92-95, 2004.
34. A. A. Quyyumi, E. K. Waller, J. Murrow et al. , "CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent, " American Heart Journal, vol. 161, no. 1, pp. 98-105, 2011.
35. H. V. Huikuri, K. Kervinen, M. Niemela et al. , "Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction, " European Heart Journal, vol. 29, no. 22, pp. 2723-2732, 2008.
36. J.-W. Lee, S.-H. Lee, Y.-J. Youn et al. , "A randomized, openlabel, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction, " Journal of Korean medical science, vol. 29, no. 1, pp. 23-31, 2014.
37. J. Ge, Y. Li, J. Qian et al. , "Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI), " Heart, vol. 92, no. 12, pp. 1764-1767, 2006.
38. S. Janssens, C. Dubois, J. Bogaert et al. , "Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial, "TheLancet, vol. 367, no. 9505, pp. 113-121, 2006.
39. R.-C. Huang, K. Yao, Y.-Z. Zou et al. , "Long term follow-up on emergent intracoronary autologous bonemarrowmononuclear cell transplantation for acute inferior-wall myocardial infarction, " NationalMedical Journal of China, vol. 86, no. 16, pp. 1107-1110, 2006.
40. M. Tendera, W. Wojakowski, W. Ruzyllo et al. , "Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial eegeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial, " European Heart Journal, vol. 30, pp. 1313-1321, 2009.
41. J. S. de Lezo, C. Herrera, M. Pan et al. , "Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function, " Revista Espanola de Cardiologia, vol. 60, no. 4, pp. 357-365, 2007.
42. R. Wen, C. Z. Pan, G. Q. Huang, Y. L. Li, J. B. Ge, and X. H. Shu, "Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging, " ChineseMedical Journal, vol. 118, no. 14, pp. 1175-1181, 2005.
43. A. Hirsch, R. Nijveldt, P. A. van der Vleuten et al. , "Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial, " European Heart Journal, vol. 32, no. 14, pp. 1736-1747, 2011.
44. L. Herbots, J. DHooge, E. Eroglu et al. , "Improved regional function after autologous bonemarrow-derived stemcell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study, " European Heart Journal, vol. 30, no. 6, pp. 662-670, 2009.
45. M. Kucia, B. Dawn, G. Hunt et al. , "Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction, " Circulation Research, vol. 95, no. 12, pp. 1191-1199, 2004.
46. S. Zhang, P. Zhang, J. Guo et al. , "Enhanced cytoprotection and angiogenesis by bonemarrow cell transplantationmay contribute to improved ischemic myocardial function, " European Journal of Cardio-Thoracic Surgery, vol. 25, no. 2, pp. 188-195, 2004.
47. S. K. Law, C. S.-L. Leung, K. L. Yau et al. , "Regulation ofmultiple transcription factors by reactive oxygen species and effects of pro-inflammatory cytokines released during myocardial infarction on cardiac differentiation of embryonic stem cells, " International Journal of Cardiology, vol. 168, no. 4, pp. 3458-3472, 2013.
48. K. T. Ji, C. Xing, F. Jiang et al. , "Benzo[a]pyrene induces oxidative stress and endothelial progenitor cell dysfunction via the activation of the NF-kB pathway, " International Journal of Molecular Medicine, vol. 31, no. 4, pp. 922-930, 2013.
49. C. E. Rochitte, J. A. C. Lima, D. A. Bluemke et al. , "Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction, " Circulation, vol. 98, no. 10, pp. 1006-1014, 1998.
50. P. R. Hansen, "Role of neutrophils in myocardial ischemia and reperfusion, " Circulation, vol. 91, no. 6, pp. 1872-1885, 1995.
51. X. Yan, A. Anzai, Y. Katsumata et al. , "Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction, " Journal ofMolecular and Cellular Cardiology, vol. 62, pp. 24-35, 2013.
52. F. van den Akker, S. C. A. de Jager, and J. P. G. Sluijter, "Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors, " Mediators of Inflammation, vol. 2013, Article ID 181020, 13 pages, 2013.
53. M. Massa, V. Rosti, M. Ferrario et al. , "Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction, " Blood, vol. 105, no. 1, pp. 199-206, 2005.
54. Z.-R. Deng, C. Yang, A.-Q. Ma, X.-Y. Chen, and T. Geng, "Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction, " Nan Fang Yi Ke Da Xue Xue Bao, vol. 26, no. 11, pp. 1637-1640, 2006.
55. Q.-C. Guo, Y. Zhang, Y.-F. Wang et al. , "Distribution and differentiation of marrow stem cells transplanted by different ways in ischemic myocardium and other organs in rabbits, " Clinical Transplantation, vol. 25, no. 6, pp. 871-877, 2011.